Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma

Mayo Clinic Proceedings

Volumn 86, Issue 8, 2011, Pages 738-743

  Kubica, Agnieszka W ^a   Rose, Peter S ^b   Weaver, Amy L ^b   Brewer, Jerry D ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BONE DISEASE; BREAST CANCER; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SIZE; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; IRRADIATION; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARA AORTIC LYMPH NODE METASTASIS; RETROSPECTIVE STUDY; SEX; SKIN DISEASE; SOFT TISSUE METASTASIS; TREATMENT DURATION; UTERUS CANCER;

EID: 79960932328     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0720     Document Type: Article

References (28)

1. Hu S, Federman DG, Ma F, Kirsner RS. Skin cancer and non-Hodgkin's lymphoma: examining the link. Dermatol Surg. 2005;31(1):76-82. (Pubitemid 40094068)
2. Montserrat E, Moreno C. Chronic lymphocytic leukaemia: a short overview. Ann Oncol. 2008;19(suppl 7):vii320-vii325.
3. Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. Lancet. 2008;371(9617):1017-1029. (Pubitemid 351389535)
4. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol. 2000;7(4):223-234. (Pubitemid 30387846)
5. Kumar RV, Mukherjee G, Bhargava MK. Malignant fibrous histiocytoma of bone. J Surg Oncol. 1990;44(3):166-170. (Pubitemid 20221430)
6. Rooser B, Willen H, Gustafson P, Alvegard TA, Rydholm A. Malignant fibrous histiocytoma of soft tissue: a population-based epidemiologic and prognostic study of 137 patients. Cancer. 1991;67(2):499-505.
7. Stein A, Hackert I, Sebastian G, Meurer M. Cutaneous malignant fibrous histiocytoma of the scalp in a renal transplant recipient. Br J Dermatol. 2006;154(1):183-185. (Pubitemid 43381344)
8. Shinjo K. Analysis of prognostic factors and chemotherapy of malignant fibrous histiocytoma of soft tissue: a preliminary report. Jpn J Clin Oncol. 1994;24(3):154-159.
9. Pezzi CM, Rawlings MS Jr, Esgro JJ, Pollock RE, Romsdahl MM. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer. 1992;69(8):2098-2103.
10. Skubitz KM, D'Adamo DR. Sarcoma. Mayo Clin Proc. 2007;82(11):1409-1432. (Pubitemid 350060138)
11. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978;41(6):2250-2266. (Pubitemid 8370196)
12. Mellemgaard A, Geisler CH, Storm HH. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol. 1994;53(4):218-222. (Pubitemid 24347966)
13. Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975;232(3):267-269.
14. Oddou S, Vey N, Viens P, et al. Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution. Leuk Lymphoma. 1998;31(1-2):187-194. (Pubitemid 28428762)
15. Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol. 2004;5(3):215-223. (Pubitemid 39359622)
16. Al-Agha OM, Igbokwe AA. Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med. 2008;132(6):1030-1035. (Pubitemid 351918713)
17. Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called "MFH") in adults. J Surg Oncol. 2008;97(4):330-339. (Pubitemid 351358581)
18. Rosenberg AE. Malignant fibrous histiocytoma: past, present, and future. Skeletal Radiol. 2003;32(11):613-618. (Pubitemid 37407852)
19. Zagars GK, Mullen JR, Pollack A. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34(5):983-994. (Pubitemid 26105436)
20. Altekruse SF, Kosary CL, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010. http://seer. cancer.gov/csr/1975-2007/. Accessed April 18, 2011.
21. Tsimberidou AM, Wen S, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol. 2009;27(6):904-910.
22. Levine PH, Hoover R. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Cancer Epidemiol Biomarkers Prev. 1992;1(6):515-517.
23. Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma. 2005;46(1):49-54.
24. Aslakson CJ, Lee G, Boomer JS, Gilman-Sachs A, Kucuk O, Beaman KD. Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: a possible mechanism for escaping immune surveillance. Am J Hematol. 1999;61(1):46-52. (Pubitemid 29218177)
25. Spanier SS, Enneking WF, Enriquez P. Primary malignant fibrous histiocytoma of bone. Cancer. 1975;36(6):2084-2098.
26. Fangman WL, Cook JL. Postradiation sarcoma: case report and review of the potential complications of therapeutic ionizing radiation. Dermatol Surg. 2005;31(8, pt 1):966-972. (Pubitemid 44795697)
27. Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol. 2000;1(3):258-261.
28. Nonaka M, Kadokura M, Ohkubo F, et al. Post radiation inflammatory malignant fibrous histiocytoma arising from the chest wall. Ann Thorac Cardiovasc Surg. 2001;7(6):371-374.